Date | Shareholder name | Reason of Disclosure | Buy/Sell and Involved Shares |
Average Price per share | Current Holdings | % of Issued Shares |
24/04/2025 | LU AN-BANG | 1312(S) | 1,707,700(S) | 5,000,000(L) | 4.39 | |
21/03/2025 | Ascendis Pharma Endocrinology Division A/S | 1701(L) | 20,568,182(L) | 18.05 | ||
21/03/2025 | Vivo Capital Fund IX(Cayman), L.P. | 1711(L) | 37,167,064(L) | 37,167,064(L) | 32.62 | |
21/03/2025 | Vivo Plenilune IX Limited | 1711(L) | 37,167,064(L) | 37,167,064(L) | 32.62 | |
21/03/2025 | Vivo Capital IX (Cayman), LLC | 1711(L) | 37,167,064(L) | 37,167,064(L) | 32.62 | |
21/03/2025 | Vivo Capital IX (Cayman), LLC | 1001(L) | 36,136,364(L) | 36,136,364(L) | 32.14 | |
21/03/2025 | Vivo Capital Fund IX(Cayman), L.P. | 1001(L) | 36,136,364(L) | 36,136,364(L) | 32.14 | |
21/03/2025 | Vivo Plenilune IX Limited | 1001(L) | 36,136,364(L) | 36,136,364(L) | 32.14 | |
21/03/2025 | Ascendis Pharma Growth Disorders A/S | 1701(L) | 7,713,068(L) | 6.77 | ||
21/03/2025 | Ascendis Pharma Bone Diseases A/S | 1701(L) | 12,855,114(L) | 11.28 | ||
21/03/2025 | Ascendis Pharma A/S | 1701(L) | 41,136,364(L) | 36.11 | ||
21/03/2025 | LU AN-BANG | 1701(L) 1313(S) | 5,000,000(L) 1,707,700(S) | 5,000,000(L) 1,707,700(S) | 4.39 1.49 | |
1 |
Remark: | (L) - Long Position, (S) - Short Position, (P) Lending; |
Real time quote last updated: 30/04/2025 17:59 | |
Real-time basic market prices of Hong Kong securities are provided by HKEx; a Designated Website authorized by the HKEx Group to provide the Service | |